Front Matter
Article Sidebar
Main Article Content
Downloads
Metrics
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Andrea Gallamini, MD (Editor), Research and Innovation Department, A. Lacassagne Cancer Center, Nice, France
Andrea Gallamini, MD, is a Consultant Hematologist at the Lacassagne Cancer Center in Nice, France. He trained in clinical research on lymphoma at the S. Croce Hospital il Cuneo, Italy, the Sophia Antipolis University of Nice, and the Onco-hematology department of the Lacassagne Cancer Center of Nice, France. His interests include the clinical applications of imaging in lymphoma and the pathobiology and prognostication of Hodgkin’s Lymphoma. He has been responsible for educational programs for “Imaging in Lymphoma” at several annual meetings of the European Hematology Association (EHA) and the American Society of Hematology (ASH). He has authored over 170 scientific publications and has been the editor for books on Hodgkin’s and non-Hodgkin’s Lymphoma, including “New Frontiers in Lymphomas”.
Malik Juweid, MD (Editor), Department of Radiology and Nuclear Medicine, Jordan University Hospital and Medical School, University of Jordan, Amman, Jordan
Malik Juweid, MD, is a professor of radiology and nuclear medicine at the University of Jordan. He did his clinical training at Heidelberg University Hospital and the Hospital of the University of Pennsylvania with research fellowship at Harvard Medical School and the National Institutes of Health (NIH). His major research interests include PET/CT imaging of lymphoma and new PET tracers. He has published 130 articles in peer-reviewed journals, 7 book chapters, and edited a book on PET/CT. Dr. Juweid has received over 10 million dollars funding for his research mostly from the US NIH and the Food and Drug Administration.